Drug development takes more than expertise—it takes connection. Our experts work across disciplines, staying aligned at every phase to power the Accelerator™ Drug Development solution and move innovation forward.
This video series will highlight key components of Accelerator™ Drug Development—including enabling technologies and cross-functional support teams—to show how Thermo Fisher Scientific uniquely delivers an integrated, single-vendor pathway that reduces complexity and improves outcomes.
In this episode, Heather Bryson, Executive Director of Global Clinical Science and Development Strategy at Thermo Fisher Scientific, examines how study design decisions made early in a program can shape its trajectory for years to come. Heather walks through the hallmarks of a well-designed clinical strategy, the design-stage mistakes that tend to surface later as costly problems, and how cross-functional collaboration strengthens the foundation of any clinical program.